Literature DB >> 6638558

Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.

E Lowenstein, W E Johnston, D G Lappas, M N D'Ambra, R C Schneider, W M Daggett, C W Akins, D M Philbin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6638558     DOI： 10.1097/00000542-198311000-00022

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  21 in total

Review 1.  Treatment of acute anaphylaxis.

Authors:  M Fisher
Journal:  BMJ       Date:  1995-09-16

2.  Prophylactic administration of histamine1 and histamine2 receptor blockers in the prevention of protamine-related haemodynamic effects.

Authors:  J Kambam; R Meszaros; W Merrill; J Stewart; B E Smith; H Bender
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

3.  Histamine 2 receptor blocker in the treatment of protamine related anaphylactoid reactions: two case reports.

Authors:  J R Kambam; W H Merrill; B E Smith
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

4.  Sheep (Ovis aries) as a model for cardiovascular surgery and management before, during, and after cardiopulmonary bypass.

Authors:  Louis DiVincenti; Robin Westcott; Candice Lee
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

5.  Increased pulmonary artery diastolic-pulmonary wedge pressure gradient after cardiopulmonary bypass.

Authors:  J Heinonen; M Salmenperä; O Takkunen
Journal:  Can Anaesth Soc J       Date:  1985-03

Review 6.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

7.  Marked systemic hypotension accompanied by pulmonary hypertension following protamine reversal of heparin: Case report.

Authors:  Takashi Horiguchi; Keiji Enzan; Junichi Matsumoto; Mamoru Kadosaki; Masahiro Suzuki
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

8.  Ketanserin in the treatment of protamine-induced pulmonary hypertension.

Authors:  P J van der Starre; C Solinas
Journal:  Tex Heart Inst J       Date:  1996

9.  Impaired myocardial function and oxygen utilization due to protamine sulfate in an isolated rabbit heart preparation.

Authors:  T W Wakefield; L E Bies; S K Wrobleski; S F Bolling; J C Stanley; M M Kirsh
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

10.  Thrombocytopenia accompanying a reaction to protamine sulfate.

Authors:  J C Horrow
Journal:  Can Anaesth Soc J       Date:  1985-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.